Pfizer`s Biologics Ngenla Receive Suppl Approval in US

Pfizer`s Biologics Ngenla Receive Suppl Approval in US
FDA
10 Jul 2025
Share Share
Ascendis`s Biologics Skytrofa Receive Suppl Approval in US

Ascendis`s Biologics Skytrofa Receive Suppl Approval in US
FDA
09 Jul 2025
Share Share
Novo Nordisk`s Biologics Sogroya Receive Suppl Approval in US

Novo Nordisk`s Biologics Sogroya Receive Suppl Approval in US
FDA
09 Jul 2025
Share Share

Enforcement Report - Week of July 9, 2025

Enforcement Report - Week of July 9, 2025
FDA
09 Jul 2025
Share Share
Dynamic Blending Specialists Recieves Warning Letter

Dynamic Blending Specialists Recieves Warning Letter
FDA
08 Jul 2025
Share Share
Libby Laboratories Recieves Warning Letter

Libby Laboratories Recieves Warning Letter
FDA
08 Jul 2025
Share Share

FDA Broadens Label for Bayer`s Kerendia to Treat Heart Failure

FDA Broadens Label for Bayer`s Kerendia to Treat Heart Failure
PRESS RELEASE
15 Jul 2025
Share Share
FDA Snubs Ultragenyx Gene Therapy Over Manufacturing Issues

FDA Snubs Ultragenyx Gene Therapy Over Manufacturing Issues
PRESS RELEASE
15 Jul 2025
Share Share
Takeda Establishes Lead in Narcolepsy Race With 2 Phase 3 Win

Takeda Establishes Lead in Narcolepsy Race With 2 Phase 3 Win
Biospace
15 Jul 2025
Share Share
AstraZeneca’s Baxdrostat Pushes Blood Pressure Lower in Phase 3

AstraZeneca’s Baxdrostat Pushes Blood Pressure Lower in Phase 3
PRESS RELEASE
15 Jul 2025
Share Share
BMS Opens RayzeBio Radiopharma Production Site in Indianapolis

BMS Opens RayzeBio Radiopharma Production Site in Indianapolis
FIERCE PHARMA
15 Jul 2025
Share Share
Research Non-profit Acquires Embattled Essa in Xoma-Backed Deal

Research Non-profit Acquires Embattled Essa in Xoma-Backed Deal
PR NEWSWIRE
15 Jul 2025
Share Share
Leo Ponies up €90 Million for Boehringer Ingelheim`s Spevigo

Leo Ponies up €90 Million for Boehringer Ingelheim`s Spevigo
BUSINESSWIRE
15 Jul 2025
Share Share
WHO recommends Gilead`s twice-yearly injection for HIV prevention

WHO recommends Gilead`s twice-yearly injection for HIV prevention
REUTERS
15 Jul 2025
Share Share
ViiV expands Licence to Allow generic HIV treatment production

ViiV expands Licence to Allow generic HIV treatment production
REUTERS
15 Jul 2025
Share Share
Merck Nears $10 Billion Deal for Respiratory Drugmaker Verona

Merck Nears $10 Billion Deal for Respiratory Drugmaker Verona
PRESS RELEASE
10 Jul 2025
Share Share